Abstract:A small molecule screen has identified a benzodioxol anilide as a ferroptosis inhibitor. To determine the structure-activity relationship (SAR) of this compound class, we have synthesized a library of 35 derivatives followed by testing their ability to inhibit cell death that was induced via RSL3, an inhibitor of the main ferroptosis regulator glutathione peroxidase 4 (GPX4), in the mouse embryonic fibroblast cell line Pfa-1. Choosing 12 representative structures, rescue experiments were performed following the tamoxifen-induced deletion of GPX4 in Pfa-1 cells to complement the pharmacological induction of ferroptosis with a genetic induction and the experiments were extended to the human epithelial lung adenocarcinoma cell line HCC827. To assess if the compounds act as radical trapping antioxidants (RTAs) that scavenge peroxy radicals which drive lipid peroxidation, a hallmark of ferroptotic cell death, we have used a fluorescence-enabled inhibited autoxidation (Fenix) assay. Mitochondria were identified as the site-of-action using an alkynylated benzodioxol probe together with a copper-catalyzed alkyne-azide cycloaddition (CuAAC)-based Alexa Fluor 488 imaging kit. Our SAR study has yielded insights into the substitution-dependent activity of benzodioxol, aniline and phenol groups as RTAs that inhibit ferroptosis which led to the design of MM-12-Urea as a new broadly applicable chemical probe. Since the investigated functional groups are common motifs in small molecule ligands or natural products, we highlight that it is worth testing their ability to act as RTAs to avoid a potentially compounding factor in their bioactivities.

Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical Scavengers

Ferroptosis and Its Multifaceted Roles in Cerebral Stroke

Discovery of novel diphenylbutene derivative ferroptosis inhibitors as neuroprotective agents

Design, synthesis, and biological evaluation of 2-amino-6-methyl-phenol derivatives targeting lipid peroxidation with potent anti-ferroptotic activities

Inhibiting ferroptosis: A novel approach for stroke therapeutics

Discovery of Novel Ortho -Aminophenol Derivatives Targeting Lipid Peroxidation with Potent Antiferroptotic Activities

Design and synthesis of sulfonamide phenothiazine derivatives as novel ferroptosis inhibitors and their therapeutic effects in spinal cord injury

A New Perspective in the Treatment of Ischemic Stroke: Ferroptosis

Discovery of 4-hydroxyl pyrazole derivatives as potent ferroptosis inhibitors

Discovery of orally bioavailable phenyltetrazolium derivatives for the acute treatment and the secondary prevention of ischemic stroke

Mechanism of ferroptosis regulating ischemic stroke and pharmacologically inhibiting ferroptosis in treatment of ischemic stroke

Synthesis and biological evaluation of ferrostatin-based diamide derivatives as new ferroptosis inhibitors

Progress of Ferroptosis in Ischemic Stroke and Therapeutic Targets

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes

Discovery of neuroprotective Agents: Potent, brain Penetrating, lipoic acid derivatives for the potential treatment of ischemic stroke by regulating oxidative stress and inflammation - a Preliminary study

Traditional Chinese medicines derived natural inhibitors of ferroptosis on ischemic stroke

Discovery of 1,2,4-triazole derivatives as novel neuroprotectants against cerebral ischemic injury by activating antioxidant response element

Design and Synthesis of 1,4‐Diformyl‐Piperazine Ferrostatin‐1 Derivatives as Novel Ferroptosis Inhibitors

Assessing the activity of benzodioxol, phenol and aniline derivatives as radical trapping antioxidants that inhibit ferroptosis

The role of ferroptosis and its mechanism in ischemic stroke

Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?